Health care stocks were declining Monday afternoon, with the NYSE Health Care Index down 0.9% and the Health Care Select Sector SPDR Fund (XLV) falling 1.1%.
The iShares Biotechnology ETF (IBB) dropped 1.1%.
In corporate news, Marinus Pharmaceuticals (MRNS) shares surged 43% after the company said it signed a deal under which Immedica Pharma will buy all of its issued and outstanding stock for $0.55 a share.
Emergent BioSolutions (EBS) shares jumped nearly 13% after HC Wainwright started coverage of the stock with a buy rating and $15 price target.
Traws Pharma (TRAW) shares tumbled over 39% after the company said it entered agreements to raise up to $72.6 million via an equity offering.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。